We believe regenerative medicine is redefining modern healthcare. Progress in medicine will be driven by the self-healing power of regenerative cells, including stem cells. Our purpose is to set new therapeutic standards by enabling physicians to use the patients’ own regenerative cells at the point of care. With the initial focus on key orthopedic and wound healing indications, we will make regenerative cell therapies broadly accessible across multiple medical fields.
The scientific experience translated into the design and development of a point-of-care tissue processing system that rapidly and efficiently isolates regenerative cells from adipose tissue. InGeneron’s process yields a very high number of cells that meet the definition for mesenchymal stem cell (MSC) stipulated by the International Society for Cellular Therapy.
InGeneron’s advanced cell separation technologies have the potential to aid physicians and veterinarians in the treatment of a number of diseases, orthopedic injuries and cosmetic procedures.
|Employees (est.) (Sept 2020)||22|
InGeneron total Funding
InGeneron latest funding size
Time since last funding
|a year ago|
InGeneron has 64 Twitter Followers. The number of followers has increased 0.7% quarter over quarter
When was InGeneron founded?
InGeneron was founded in 2006.
Who are InGeneron key executives?
InGeneron's key executives are Ron Stubbers, Eckhard Alt and Fabian Alt.
How many employees does InGeneron have?
InGeneron has 22 employees.
Who are InGeneron competitors?
Competitors of InGeneron include E-Qure, Obalon Therapeutics and MicrofluidX.
Where is InGeneron headquarters?
InGeneron headquarters is located at 8205 El Rio St, Houston.
Where are InGeneron offices?
InGeneron has offices in Houston and München.
How many offices does InGeneron have?
InGeneron has 2 offices.
Receive alerts for 300+ data fields across thousands of companies